Loading in 2 Seconds...
Loading in 2 Seconds...
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market
Published on: July 2014
No. of Pages: 143
Reports and Intelligence
GBI Research, a leading business intelligence provider, has released its latest research report, “Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market”. The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to increase significantly over the forecast period across the leading eight developed nations, from $5.1 billion in 2013 to $7.9 billion in 2020. This equates to a Compound Annual Growth Rate (CAGR) of 6.6%. Growth will be driven by novel therapies entering the squamous cell carcinoma market segment, which is currently lacking effective treatment, unlike the non-squamous market segment.
The report focuses on the increasing differentiation between the three main NSCLC subtypes: squamous cell, adenocarcinoma, and large cell carcinoma. Common genetic and molecular aberrations within these histologies are being extensively researched and targeted by novel therapeutics and so the treatment algorithm between histological subtypes is forecast to become more differentiated over the forecast period. Most notably, patients with squamous cell carcinoma are set to benefit from crucial first- and second-line therapies in the form of Yervoy (ipilimumab) and nivolumab, having relied on generic chemotherapy for the past decade.
Get full access to TOC at: http://www.reportsandintelligence.com/non-small-cell-lung-cancer-to-2020-new-therapies-to-enhance-treatment-segmentation-and-drive-growth-in-an-increasingly-competitive-market/table-of-contents
Get access to detailed information at: http://www.reportsandintelligence.com/non-small-cell-lung-cancer-to-2020-new-therapies-to-enhance-treatment-segmentation-and-drive-growth-in-an-increasingly-competitive-market
Request for Discount at: